Correlation Between Relay Therapeutics and Cns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Relay Therapeutics and Cns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Relay Therapeutics and Cns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Relay Therapeutics and Cns Pharmaceuticals, you can compare the effects of market volatilities on Relay Therapeutics and Cns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Relay Therapeutics with a short position of Cns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Relay Therapeutics and Cns Pharmaceuticals.
Diversification Opportunities for Relay Therapeutics and Cns Pharmaceuticals
0.51 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Relay and Cns is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Relay Therapeutics and Cns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cns Pharmaceuticals and Relay Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Relay Therapeutics are associated (or correlated) with Cns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cns Pharmaceuticals has no effect on the direction of Relay Therapeutics i.e., Relay Therapeutics and Cns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Relay Therapeutics and Cns Pharmaceuticals
Given the investment horizon of 90 days Relay Therapeutics is expected to under-perform the Cns Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Relay Therapeutics is 2.53 times less risky than Cns Pharmaceuticals. The stock trades about -0.3 of its potential returns per unit of risk. The Cns Pharmaceuticals is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 14.00 in Cns Pharmaceuticals on August 25, 2024 and sell it today you would lose (2.00) from holding Cns Pharmaceuticals or give up 14.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Relay Therapeutics vs. Cns Pharmaceuticals
Performance |
| Timeline |
| Relay Therapeutics |
| Cns Pharmaceuticals |
Relay Therapeutics and Cns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Relay Therapeutics and Cns Pharmaceuticals
The main advantage of trading using opposite Relay Therapeutics and Cns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Relay Therapeutics position performs unexpectedly, Cns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cns Pharmaceuticals will offset losses from the drop in Cns Pharmaceuticals' long position.| Relay Therapeutics vs. Stoke Therapeutics | Relay Therapeutics vs. Pliant Therapeutics | Relay Therapeutics vs. Black Diamond Therapeutics | Relay Therapeutics vs. Arvinas |
| Cns Pharmaceuticals vs. ZyVersa Therapeutics | Cns Pharmaceuticals vs. Immix Biopharma | Cns Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Cns Pharmaceuticals vs. Ocean Biomedical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |